Propofol-remifentanyl Versus Dexmedetomidine in Awake Craniotomy: Impact on Electroclinical Seizure Activity
- Conditions
- SeizuresCraniotomyDexmedetomidinePropofolRemifentanilCerebral TumorNeurophysiology
- Interventions
- Registration Number
- NCT05103735
- Brief Summary
Awake craniotomy require a cooperative patient during resection neurosurgery phase. Anesthesiologist should guarantee analgesia, sedation, nausea and vomiting prevention, while maintaining normal vital parameters.
Neurosurgeon could be help by Intraoperative electrocorticography to maximise lesion resection and avoiding neurologic sequelae. Propofol and remifentanyl have been largely used. Dexmedetomidine represents an alternative. However little is known about the role of dexmedetomidine on Intraoperative electrocorticography.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 170
- PATIENTS UNDERGOING AWAKE CRANIOTOMY FOR TUMOR RESECTION (EXCLUDED E.G. SURGERY OF EPILEPSIA)
- INTRAOPERATIVE MONITORING (IOM) WITH ELECTROCORTICOGRAPHY
- AWAKE-AWAKE-AWAKE TECHNIQUE
- AGE <18 YEARS OLD
- NON AWAKE-AWAKE-AWAKE TECHNIQUE
- ABSENCE OF IOM
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description PROPOFOL-REMIFENTANYL Propofol Awake craniotomy under propofol-remifentanil sedation. Propofol and remifentanyl was administered through continuous intravenous infusion, starting 30 minutes prior to surgery. The end of the infusion was at the end of the surgical procedure. Propofol dosage: 0.2-2 mk/kg/h Remifentanyl dosage: 0.01-0.1 mcg/kg/min
- Primary Outcome Measures
Name Time Method SEIZURE ACTIVITY DURING TUMOR RESECTION PHASE OF THE AWAKE CRANIOTOMY INCIDENCE OF ELECTRO-CLINICAL SEIZURE ACTIVITY IN THE TWO GROUPS DURING RESECTIVE PHASE OF AWAKE CRANIOTOMY EVALUATED WITH ELECTROCORTICOGRAPHY.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Cristian Deana
🇮🇹Udine, Italy